SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-21-029398
Filing Date
2021-02-26
Accepted
2021-02-26 17:20:46
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm217250d2_defa14a.htm DEFA14A 30776
2 GRAPHIC tm217250d2_defa14aimage001.jpg GRAPHIC 33356
  Complete submission text file 0001104659-21-029398.txt   78036
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36020 | Film No.: 21691355
SIC: 2834 Pharmaceutical Preparations